204 related articles for article (PubMed ID: 36269132)
1. Health influence of SARS-CoV-2 (COVID-19) on cancer: a review.
Parise R; Li YE; Nadar RM; Ramesh S; Ren J; Govindarajulu MY; Moore T; Dhanasekaran M
Acta Biochim Biophys Sin (Shanghai); 2022 Oct; 54(10):1395-1405. PubMed ID: 36269132
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
3. Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Patients Infected by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).
Heffernan DS; Evans HL; Huston JM; Claridge JA; Blake DP; May AK; Beilman GS; Barie PS; Kaplan LJ
Surg Infect (Larchmt); 2020 May; 21(4):301-308. PubMed ID: 32310715
[No Abstract] [Full Text] [Related]
4. COVID-19 and oncological disease.
Šálek T; Slopovský J; Pörsök Š; Pazderová N; Mináriková Z; Zomborská E; Špánik B
Klin Onkol; 2021; 34(3):211-219. PubMed ID: 34362259
[TBL] [Abstract][Full Text] [Related]
5. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
6. A Reminder of Skin Cancer During the COVID-19 Pandemic.
Šitum M; Filipović N; Buljan M
Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
8. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
9. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
García IG; Rodriguez-Rubio M; Mariblanca AR; de Soto LM; García LD; Villatoro JM; Parada JQ; Meseguer ES; Rosales MJ; González J; Arribas JR; Carcas AJ; de la Oliva P; Borobia AM
Trials; 2020 Jun; 21(1):466. PubMed ID: 32493475
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 in pediatric cancer: a systematic review.
Schlage S; Lehrnbecher T; Berner R; Simon A; Toepfner N
Eur J Pediatr; 2022 Apr; 181(4):1413-1427. PubMed ID: 35006377
[TBL] [Abstract][Full Text] [Related]
11. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy.
Dashraath P; Wong JLJ; Lim MXK; Lim LM; Li S; Biswas A; Choolani M; Mattar C; Su LL
Am J Obstet Gynecol; 2020 Jun; 222(6):521-531. PubMed ID: 32217113
[TBL] [Abstract][Full Text] [Related]
12. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
13. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC
JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899
[TBL] [Abstract][Full Text] [Related]
15. An Analysis of 38 Pregnant Women With COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes.
Schwartz DA
Arch Pathol Lab Med; 2020 Jul; 144(7):799-805. PubMed ID: 32180426
[TBL] [Abstract][Full Text] [Related]
16. Current Therapeutics for COVID-19, What We Know about the Molecular Mechanism and Efficacy of Treatments for This Novel Virus.
Narayanan D; Parimon T
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887042
[TBL] [Abstract][Full Text] [Related]
17. Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.
Mazidimoradi A; Tiznobaik A; Salehiniya H
J Gastrointest Cancer; 2022 Sep; 53(3):730-744. PubMed ID: 34406626
[TBL] [Abstract][Full Text] [Related]
18. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.
Nussbaumer-Streit B; Mayr V; Dobrescu AI; Chapman A; Persad E; Klerings I; Wagner G; Siebert U; Christof C; Zachariah C; Gartlehner G
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013574. PubMed ID: 32267544
[TBL] [Abstract][Full Text] [Related]
19. Clinical and epidemiological aspects of SARS-CoV-2 infection among pregnant and postpartum women in Mozambique: a prospective cohort study.
Charles CM; Osman NB; Arijama D; Matingane B; Sitoé T; Kenga D; Lorenzoni C; Luís E; Pacagnella RC; Sacarlal J;
Reprod Health; 2022 Jul; 19(1):164. PubMed ID: 35854384
[TBL] [Abstract][Full Text] [Related]
20. The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy.
Preskorn SH
J Psychiatr Pract; 2020 May; 26(3):219-227. PubMed ID: 32421292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
